<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Asrani K</submitter><funding>NCI NIH HHS</funding><funding>National Institutes of Health</funding><pagination>425-437</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8599638</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>255(4)</volume><pubmed_abstract>Neuroendocrine prostate cancer (NEPC) is a rare but aggressive histologic variant of prostate cancer that responds poorly to androgen deprivation therapy. Hybrid NEPC-adenocarcinoma (AdCa) tumors are common, often eluding accurate pathologic diagnosis and requiring ancillary markers for classification. We recently performed an outlier-based meta-analysis across a number of independent gene expression microarray datasets to identify novel markers that differentiate NEPC from AdCa, including up-regulation of insulinoma-associated protein 1 (INSM1) and loss of Yes-associated protein 1 (YAP1). Here, using diverse cancer gene expression datasets, we show that Hippo pathway-related genes, including YAP1, are among the top down-regulated gene sets with expression of the neuroendocrine transcripti</pubmed_abstract><journal>The Journal of pathology</journal><pubmed_title>Reciprocal YAP1 loss and INSM1 expression in neuroendocrine prostate cancer.</pubmed_title><pmcid>PMC8599638</pmcid><funding_grant_id>P30 CA006973</funding_grant_id><funding_grant_id>P50CA58236</funding_grant_id><funding_grant_id>R01 CA234715</funding_grant_id><funding_grant_id>P50 CA058236</funding_grant_id><funding_grant_id>P01 CA163227</funding_grant_id><funding_grant_id>P50CA087186</funding_grant_id><funding_grant_id>P50 CA097186</funding_grant_id><pubmed_authors>De Marzo AM</pubmed_authors><pubmed_authors>Hanratty B</pubmed_authors><pubmed_authors>Asrani K</pubmed_authors><pubmed_authors>Coleman I</pubmed_authors><pubmed_authors>Vidotto T</pubmed_authors><pubmed_authors>Yegnasubramanian S</pubmed_authors><pubmed_authors>Lotan TL</pubmed_authors><pubmed_authors>Tsai HK</pubmed_authors><pubmed_authors>Torres AF</pubmed_authors><pubmed_authors>Luo J</pubmed_authors><pubmed_authors>Haffner MC</pubmed_authors><pubmed_authors>Nelson PS</pubmed_authors><pubmed_authors>Corey E</pubmed_authors><pubmed_authors>Woo J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Reciprocal YAP1 loss and INSM1 expression in neuroendocrine prostate cancer.</name><description>Neuroendocrine prostate cancer (NEPC) is a rare but aggressive histologic variant of prostate cancer that responds poorly to androgen deprivation therapy. Hybrid NEPC-adenocarcinoma (AdCa) tumors are common, often eluding accurate pathologic diagnosis and requiring ancillary markers for classification. We recently performed an outlier-based meta-analysis across a number of independent gene expression microarray datasets to identify novel markers that differentiate NEPC from AdCa, including up-regulation of insulinoma-associated protein 1 (INSM1) and loss of Yes-associated protein 1 (YAP1). Here, using diverse cancer gene expression datasets, we show that Hippo pathway-related genes, including YAP1, are among the top down-regulated gene sets with expression of the neuroendocrine transcripti</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Dec</publication><modification>2026-06-04T03:00:53.27Z</modification><creation>2025-04-04T19:38:01.384Z</creation></dates><accession>S-EPMC8599638</accession><cross_references><pubmed>34431104</pubmed><doi>10.1002/path.5781</doi></cross_references></HashMap>